Core Viewpoint - Guo Xin Health (000503) has maintained steady revenue growth over the past three years, exceeding 300 million yuan annually, and does not face any risk warning as per the Shenzhen Stock Exchange regulations [1] Group 1: Financial Performance - The company has reported consistent revenue growth, with annual revenues surpassing 300 million yuan for the last three years [1] - Detailed performance data can be referenced in the company's annual reports for the past three years [1] Group 2: Strategic Initiatives - The company plans to enhance the effectiveness of comprehensive reforms and improve coordination between front, middle, and back offices to increase operational efficiency [1] - There is a focus on adjusting the business structure and implementing cost reduction and efficiency improvement measures across the company [1] - The overall performance for the year will be disclosed in future company announcements [1]
国新健康:近三年营业收入持续保持稳步增长,均超过三亿元